Company Profile

SNJ Pharma Inc
Profile last edited on: 12/26/22      CAGE: 8KQY4      UEI: KDZUVLP7VDH8

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2020
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1124 West Carson Street MRL Building 3F
Torrance, CA 90502
   (714) 261-1364
   N/A
   N/A
Location: Single
Congr. District: 43
County: Los Angeles

Public Profile

A startup recently located in the BioLabs-LA at the Lundquist, an Institute for Biomedical Innovation at Harbor-UCLA Medical Center., SNJ Pharma Inc. was established explcitly to develop the portfolios of the Korean based firm JINIS Inc. for access to the global market. JINIS Inc. was originally founded in Korea by by Dr. Hyeon Jin Kim - now also President of SNJ Pharma here in the US. After 20 years of rigorous R/D at JINIS, SNJ Pharma is now the means by which to develop the portfolios of JINIS that are at various preclinical and clinical stages. An approriate BSIR endeavor???

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 1 NIH $449,594
Project Title: Development of the Plasmin-independent Thrombolytic Agent for the Treatment of Acute Ischemic Stroke

Key People / Management

  Hyeon Jin Kim -- President

  Seong Hong -- Scientific Advisor of SNJ Pharma

Company News

There are no news available.